Key Insights

Highlights

Treatment Research

4 treatments under study, led by Dafodil Prosthesis

Research Leaders

8 sponsors active, led by Instituto Dante Pazzanese de Cardiologia

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Active Not Recruiting1
Unknown1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07413965Not ApplicableRecruitingPrimary

TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

NCT01980797Active Not RecruitingPrimary

International Bicuspid Aortic Valve Consortium (BAVCon)

NCT06688448Not ApplicableRecruiting

Valvular Assessment of New Generation Aortic Replacement Devices

NCT05656820UnknownPrimary

Bicuspid Echocardiac Study Team（BEST）

Showing all 4 trials

Research Network

Common Treatments

  • Dafodil Prosthesis1
  • The Open Chest Surgery To Replace The Aortic Valve1
  • Transcatheter Aortic Valve Replacement1
  • Aortic Valve Replacement Inspires Resilia Prosthesis1

Active Sponsors

  • Instituto Dante Pazzanese de Cardiologia1
  • Boston University1
  • Icahn School of Medicine at Mount Sinai1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • Suzhou Municipal Hospital1

Top Investigators

Related Conditions

  • Thoracic Aortic Disease In Patients With A Bicuspid Aortic Valve1
  • Aortic Regurgitation Disease1
  • Aortic Valve Calcification1

Activity Timeline